CMS froze Medicare enrollment for new O&P providers in February — the moratorium's six-month clock is nearly up

Since February 27, new prosthetics and orthotics suppliers have been locked out of Medicare enrollment under a CMS fraud-control measure. For patients, the consequence is not a billing freeze — it is a quieter limit on access, especially in areas that already have few providers.

A person adjusting a boot around a below-knee prosthesis outside a cafe

On February 27, 2026, the Centers for Medicare & Medicaid Services quietly shut the door on new suppliers trying to enter the durable medical equipment, prosthetics, orthotics, and supplies program — the billing category that covers nearly everything an amputee or limb-different person gets through Medicare. The stated reason was fraud and abuse. The mechanism was a moratorium on new enrollment.

The O&P EDGE reported this week on the compliance risks this creates for existing providers. That is a real concern for clinics. But the moratorium also has consequences on the other side of the appointment room.

What the moratorium actually does

DMEPOS is not a device type — it is a supplier category. O&P clinics that bill Medicare for prosthetics, orthotics, and related supplies do so as enrolled DMEPOS suppliers. The enrollment moratorium means that any clinic, group, or individual practitioner that is not already enrolled as of February 27 cannot begin billing Medicare for DMEPOS items until CMS lifts the freeze.

The moratorium does not affect:

  • Providers already enrolled and billing Medicare before the freeze date
  • Existing patients receiving care from currently enrolled clinics
  • Claims submitted under already-established provider numbers

What it does affect is the edge where supply and demand meet access. A new O&P clinic opening in a rural county cannot enroll during the moratorium. A practitioner who left private practice and wants to return cannot re-enroll. A group practice opening a second location as a separate enrollment cannot add it. Wherever the provider network was thin before February 27, it cannot grow during the freeze.

Why CMS imposed it

CMS has used enrollment moratoria in DMEPOS before. The category has a documented history of fraudulent billing — suppliers billing for equipment not delivered, suppliers billing for patients who were not clients, organized schemes using stolen beneficiary information to generate claims. The February 2026 moratorium follows that pattern: a system-wide pause to allow enhanced screening, background checks, and site visits before new suppliers join the program.

The moratorium had a planned six-month duration from the imposition date. Six months from February 27 is August 27, 2026.

That deadline is three and a half weeks away.

What happens next

CMS has several options when a moratorium’s planned end date arrives. It can lift the freeze and reopen enrollment. It can extend the moratorium by another period — past moratoria have been extended multiple times. It can convert the moratorium to a different access control — enhanced screening requirements, surety bond increases, accreditation mandates — before reopening. Or it can lift the moratorium in some geographic areas while maintaining it in others, as happened in previous DMEPOS fraud-control cycles.

The O&P Edge article’s focus on compliance risk for existing providers suggests the industry is preparing for the possibility that the moratorium is extended or replaced with stringent ongoing requirements, not simply lifted on the anniversary date.

CMS will publish its decision through the Federal Register and DMEPOS supplier updates. The American Orthotic and Prosthetic Association tracks these changes and has been engaged on the access implications since the freeze was announced.

The patient-facing consequence

If you are currently receiving prosthetics or orthotics care from a Medicare-enrolled provider, the moratorium has not interrupted your care and almost certainly has not changed how your claims are processed. The practical effect lands elsewhere.

The provider access gap in rural and underserved areas was a documented problem before the moratorium. In regions where the nearest enrolled O&P clinic is a significant drive, the moratorium’s enrollment freeze means that gap cannot be filled by new entrants to the market for however long the freeze holds. If a clinic in an underserved area closes during the moratorium period — because the owner retired, because the practice was acquired and restructured, because the building lease ended — the enrolled provider number does not automatically transfer to a new entity. Someone would have to re-enroll, and they cannot.

For Medicare beneficiaries in areas where this plays out, the relevant questions are:

  • Is your current O&P clinic currently enrolled and billing Medicare without interruption?
  • If you were planning to establish care with a new provider, is that provider already enrolled?
  • If you live in an area with limited provider options and are seeing a clinic that may face a transition, it is worth confirming their Medicare enrollment status before that transition occurs rather than after.

None of those questions require you to understand DMEPOS enrollment law. They can be asked directly at the front desk of any clinic. The answer should be straightforward.

The next useful question

CMS has not announced whether the moratorium will end August 27 or continue. O&P professional associations have been pushing for clarity on the path to reopening enrollment, with particular attention to the access implications in underserved markets. A moratorium that began as a short-term fraud-control measure has accumulated enough elapsed time that its policy effects on network adequacy are now worth naming as a separate concern.

When CMS publishes its decision — whether that is a lift, an extension, or a replacement mechanism — the operational question for patients and referring clinicians is how quickly new providers can actually move through the enrollment process once the door reopens. Past enrollment cycles in DMEPOS have had processing times measured in months, not days. A formal end to the moratorium and functional access to new enrolled providers are not the same event.


Amputee News does not provide individualized insurance, billing, or benefits advice. Medicare DMEPOS coverage and supplier enrollment status can change. For questions about your specific coverage, contact your Medicare plan directly or call 1-800-MEDICARE. For help navigating access issues, a State Health Insurance Assistance Program (SHIP) counselor can review your situation at no cost.

Source notebook: This reporting draws on O&P EDGE: DMEPOS Enrollment Moratorium — Compliance Risks for O&P Providers (August 2026) ↗. We link out so you can follow the receipts.